Drugs & Targets FDA grants Fast Track Designation to UB-VV111 in vivo CAR T-cell therapy October 03, 2025Vol.51 No.36
Drugs & Targets FDA approves Keytruda Qlex injection for subcutaneous use in 38 tumor indications September 26, 2025Vol.51 No.35By Jacquelyn Cobb
Drugs & Targets FDA grants priority review to HER2-directed therapy as first-line treatment of HER2-positive metastatic breast cancer September 26, 2025Vol.51 No.35
Drugs & Targets FDA approves gemcitabine intravesical system for non-muscle invasive bladder cancer September 19, 2025Vol.51 No.34
Drugs & Targets FDA approves Bosaya and Aukelso, denosumab biosimilars, for osteoporosis September 19, 2025Vol.51 No.34
Drugs & Targets FDA approves selumetinib for pediatric neurofibromatosis indication September 19, 2025Vol.51 No.34
Drugs & Targets FDA, Telix agree on NDA resubmission pathway for TLX101-CDx, an investigational agent for glioma imaging September 19, 2025Vol.51 No.34
Drugs & Targets EC grants conditional marketing authorization to Zemcelpro September 19, 2025Vol.51 No.34
